Science-First.
Founder-Led.
Australian Made.

GlowSense is a GMP-certified cosmetic contract manufacturer and R&D platform based in Ravenhall, Victoria — home to the world's first patent-pending cold-process marine bio-spicule co-formulation technology.

🏭
GMP Certified

ISO 22716 · Audited by SGS

🔬
Patent Pending

AU 2026901796 · One Pot Process (OPP) Method

⚗️
RDTI Registered

R&D Tax Incentive programme

🌿
Cold-Process Only

Zero heat degradation of actives

🇦🇺
Made in Australia

Ravenhall, Victoria

Built by a Chemist.
Driven by a Problem
No One Had Solved.

Conventional cosmetic manufacturing has an unspoken failure: the actives delivering the most meaningful clinical results — peptides, growth-factor mimetics, live probiotics, stable Vitamin C derivatives — are precisely the ones destroyed by the 70–75°C emulsification temperatures standard formulation requires.


GlowSense was founded to solve this at the manufacturing level. Satish, a hands-on formulation chemist with GMP operations expertise, developed the OPP Method — a cold-process, single-vessel co-formulation technique using marine bio-spicules (Haliclona sp., oxea-type, 100–400 µm) as physical penetration enhancers. Peer-reviewed science published in Molecular Pharmaceutics (Zhang et al., 2017) confirms 33–72× transdermal enhancement with zero systemic toxicity and full self-limiting skin recovery.


A global prior art search across AU, US, EP, CN, KR and WO jurisdictions confirmed zero prior art for this cold-process co-formulation application. Patent application AU 2026901796 was filed 5 March 2026.

S
Satish
Founder & Director · GlowSense Pty Ltd

Chemistry background with deep hands-on expertise across cosmetic formulation science, GMP manufacturing operations, RDTI-registered R&D programme design and Australian regulatory compliance. Inventor of the OPP Method. Architect of GlowSense's dual B2B contract manufacturing and DTC brand strategy.

Formulation ChemistryGMP OperationsPatent InventorTransdermal ScienceRDTI R&D
O
Obula Reddy Goner
Co-Director · GlowSense Pty Ltd

Co-director and business operations partner, bringing complementary commercial expertise to GlowSense's manufacturing scale-up, client relations and growth strategy.

Corporate Structure
GlowSense Pty Ltd — ABN 88 678 959 290
Operating entity · GMP manufacturing · 114 Eucumbene Drive, Ravenhall VIC 3023

GlowSense Holdings Pty Ltd — ABN 93 678 959 307
IP-holding entity · Patent AU 2026901796 owner

From Bench to
Patent-Pending Platform

2024
2024 — Foundation

GlowSense Established · ISO 22716 GMP Secured

Both entities incorporated. ISO 22716 certification awarded by international auditing agency SGS. First contract manufacturing clients onboarded. DTC brand launched via glowsense.com.au. MOQ set at 50 kg per batch with single-shift capacity.

2025
2025 — R&D Programme

RDTI-Registered Research · OPP Bench Trials

R&D programme registered under the Australian R&D Tax Incentive (RDTI) with RADBE Consulting. Bio-spicule penetration enhancement research commences. Cold-process co-formulation trials demonstrate 33–91× transdermal delivery enhancement. Industry Growth Program Advisory Service approved (IGPAS007206).

Mar 26
5 March 2026 — Patent Filed

AU 2026901796 · Zero Global Prior Art Confirmed

Provisional patent application filed via IP Australia. Voluntary amendments submitted (19 SOPA items, 11 restructured claims, 4 formal documents). Global prior art search across AU, US, EP, CN, KR and WO confirms zero prior art — validating the OPP cold-process co-formulation as a genuinely novel platform.

2026
2026 — Commercialisation

Seed Round · B2B Contracts · Consumer Launch

AUD $500K angel seed round targeting ESIC-eligible structure. B2B contracts including GlowBare (Glow Bare Skin Pty Ltd). GS-003 Niacinamide Serum and GS-004 Vitamin C Serum in production. Amazon AU listing strategy and TikTok content playbook complete.

Mar 27
March 2027 — Global IP

PCT International Patent Filing

6-phase global patent roadmap active. PCT filing to cover US, EU, UK, Japan and South Korea. International protection will underpin technology licensing deals and global manufacturing partnerships.

What Makes Us
Fundamentally Different

Every Australian GMP manufacturer offers ISO 22716. Only GlowSense offers a patent-pending delivery platform that makes heat-sensitive actives viable at therapeutic concentrations.

— Standard Contract Manufacturers

Hot-process emulsification at 70–75°C degrades peptides, probiotics, Vitamin C and enzymatic actives during manufacture
Active delivery limited to stratum corneum surface — no transdermal penetration enhancement mechanism
Multiple-vessel process with separate heating and cooling phases — higher complexity and contamination risk
No proprietary IP — any GMP-accredited competitor can replicate services identically, creating race-to-bottom pricing
Efficacy claims compete on ingredient concentration alone ("10% niacinamide") — not actual epidermal bioavailability

✦ GlowSense OPP Platform

Ambient-temperature manufacture throughout — every heat-sensitive active delivered 100% intact from batch to shelf
33–91× peer-reviewed transdermal delivery enhancement via Haliclona sp. bio-spicule microchannels (PubMed confirmed, 2017)
Single-vessel co-formulation — spicules and actives combined simultaneously, reducing processing steps and risk
Patent-pending IP (AU 2026901796), zero global prior art — a technology moat no GMP certificate alone can replicate
Claims shift from concentration to delivery — "33× transdermal bioavailability" is a categorically stronger market position

Our Principles

🔬

Science Over Marketing

Every efficacy claim is backed by published peer-reviewed data and our bench-trial results. We formulate by mechanism, not by trend, and we show our work.

🌿

Cold-Process Philosophy

Heat destroys the actives that matter most. Ambient-temperature manufacturing is non-negotiable for us — it is literally written into our patent claims.

🤝

Partner-First Manufacturing

Your formulation is your IP. We sign NDAs, protect your brief, and operate as a transparent partner — not a competitor. Our success is measured by yours.

🇦🇺

Australian Quality Standards

ISO 22716 certified by SGS, TGA-aligned documentation, and RDTI-registered R&D. Consistent rigour on every batch regardless of order size.

Platform Thinking

The OPP Method is a platform technology. We are building the manufacturing infrastructure for the next generation of transdermal-effective cosmetics.

📊

Transparent R&D

RDTI-registered activities, full batch records, open communication on what works and why. No overselling. No black boxes.

Partner with Australia's
Most Advanced Delivery Platform

Whether you're a brand seeking a manufacturer, or an investor in deep-science skincare — we're ready to talk.